BONVIVA 100mg tablets drug use results surveillance
Not Applicable
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000023992
- Lead Sponsor
- Chugai Pharmaceutical Co. Ltd. Pharmacovigilance Dept.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
Not provided
Exclusion Criteria
No criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety 1.Adverse drug reaction status/incidence 2.Identification and confirmation of factors which affect safetyprofiles
- Secondary Outcome Measures
Name Time Method Efficacy 1.Percent change from baseline in bone mineral density (BMD) 2.Percent change from baseline in bone turnover markers 3.Incidence of new fracture (including exacerbation of fracture)